We're always providing new and informative resources regarding mesothelioma treatment including: Clinical Trials, Conventional Treatments, Experimental Treatments, and more. Check back often for the most recent advances in mesothelioma treatments.
Despite Onconase Trial Results Quintessence Moves Ahead
In an article posted in this column a few weeks ago, it was reported that researchers at Madison-based Quintessence Bioscience were waiting for the results of a Phase IIIb clinical trial from Alfacell Corp., a significant East Coast competitor, on an anti-cancer therapeutic compound, Onconase. QBI-139, Quintessence's lead drug candidate, is very similar to Onconase but has not yet gone through clinical testing. - 6/6/08
A Case Report: Malignant Mesothelioma with Unexpected Contralateral Mediastinal Shift
An unusual clinical feature of mesothelioma is the presentation of contralateral mediastinal shift due to pleural mesothelioma tissue, rather than a pleural effusion. - 5/1/08
Heated Intraoperative Intraperitoneal Chemotherapy Developed by Renowned Surgeon
Dr. Paul Sugarbaker, renowned oncologic surgeon specializing in mesothelioma at the Washington Cancer Institute, developed a leading-edge surgical procedure to treat mesothelioma called heated intraoperative intraperitoneal chemotherapy. - 4/29/08.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment